Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ProVee Urethral Expander System IDE Study (ProVIDE)

NCT: NCT05186740 · ACTIVE_NOT_RECRUITING

NCT IDNCT05186740
StatusACTIVE_NOT_RECRUITING
Start Date2022-06-09
Completion2028-12

Brief Summary

A study to evaluate the safety, performance, and effectiveness of the ProVee Urethral Expander System (Investigational Device) when used in subjects with symptomatic urinary obstruction related to benign prostatic hyperplasia (BPH).

Frequently Asked Questions

What is ProVee Urethral Expander System IDE Study (ProVIDE)?

ProVee Urethral Expander System IDE Study (ProVIDE) is a clinical trial registered under NCT05186740. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05186740?

The current status of NCT05186740 (ProVee Urethral Expander System IDE Study (ProVIDE)) is: ACTIVE_NOT_RECRUITING.

When did ProVee Urethral Expander System IDE Study (ProVIDE) start?

ProVee Urethral Expander System IDE Study (ProVIDE) started on 2022-06-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑